본문 바로가기
KERD
논문KCI 등재

Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: Evidence suggests that the gastrointestinal microbiome plays a significant role in the biology of metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether disparities in the gut microbiome across intestinal tissular compartments between the sexes lead to MASLD pathogenesis. Methods: Sex-specific analyses of microbiome composition in two anatomically distinct regions of the gut, the small intestine and colon, were performed using an experimental model of MASLD. The study involved male and female spontaneously hypertensive rats and the Wistar-Kyoto control rat strain, which were fed either a standard chow diet or a high-fat diet for 12 weeks to induce MASLD (12 rats per group). High-throughput 16S sequencing was used for microbiome analysis. Results: There were significant differences in the overall microbiome composition of male and female rats with MASLD, including variations in topographical gut regions. The beta diversity of the jejunal and colon microbiomes was higher in female rats than in male rats (PERMANOVA P-value=0.001). Sex-specific analysis and discriminant features using LEfSe showed considerable variation in bacterial abundance, along with distinct functional properties, in the jejunum and colon of animals with MASLD. Significantly elevated levels of lipopolysaccharide and protein expression of Toll-like receptor 4 were observed in the livers of male rats with MASLD compared with their female counterparts. Conclusions: This study uncovered sexual dimorphism in the gut microbiome of MASLD and identified microbial heterogeneity within intestinal compartments. Insights into sex-specific variations in gut microbiome composition could facilitate customised treatment strategies.

Abstract

Background/Aims: Evidence suggests that the gastrointestinal microbiome plays a significant role in the biology of metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether disparities in the gut microbiome across intestinal tissular compartments between the sexes lead to MASLD pathogenesis. Methods: Sex-specific analyses of microbiome composition in two anatomically distinct regions of the gut, the small intestine and colon, were performed using an experimental model of MASLD. The study involved male and female spontaneously hypertensive rats and the Wistar-Kyoto control rat strain, which were fed either a standard chow diet or a high-fat diet for 12 weeks to induce MASLD (12 rats per group). High-throughput 16S sequencing was used for microbiome analysis. Results: There were significant differences in the overall microbiome composition of male and female rats with MASLD, including variations in topographical gut regions. The beta diversity of the jejunal and colon microbiomes was higher in female rats than in male rats (PERMANOVA P-value=0.001). Sex-specific analysis and discriminant features using LEfSe showed considerable variation in bacterial abundance, along with distinct functional properties, in the jejunum and colon of animals with MASLD. Significantly elevated levels of lipopolysaccharide and protein expression of Toll-like receptor 4 were observed in the livers of male rats with MASLD compared with their female counterparts. Conclusions: This study uncovered sexual dimorphism in the gut microbiome of MASLD and identified microbial heterogeneity within intestinal compartments. Insights into sex-specific variations in gut microbiome composition could facilitate customised treatment strategies.

참고문헌 (37)

관련 논문AI추천

Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction- Associated Steatotic Liver DiseaseChao Cui, Jingfei Shi, Kai Wang, Shuai Gao거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제4호Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseAntonio Gil-Gómez, Huma Saeed, Jasmohan S. Bajaj, Jeremy Burton, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khan대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver diseaseChristopher D. Byrne, Erica Jennison대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제1호Bacteroides eggerthii ameliorates metabolic dysfunction associated steatotic liver disease through host–microbe signaling and highlights 2-hydroxyisocaproate as a potential effectorChoong Hwan Lee, Geum Ok Baek, Hyun Sun Jung, Jae Youn Cheong, Ji Eun Han, Ji Yi Choi, Jung Woo Eun, Moon Gyeong Yoon, Na-Rae Lee, Se Ha Jang, Soon Sun Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis석기태, 윤기수, 한상학, Byoung Kook Kim, Byung Yong Kim, Do Yup Lee, Haripriya Gupta, Hotaik Sung, Hyeong Seop Kim, Min Jea Shin, Na Young Lee, Sang Jun Yoon, Tae Sik Park, Ye Rin Choi대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제1호Bioactive metabolites: A clue to the link between MASLD and CKD?Christopher D. Byrne, Dan-Qin Sun, Giovanni Targher, Jia-Hui Zhang, Liang Luo, Li-Li Chen, Ming-Hua Zheng, Wen-Ying Chen, Yan Ni대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호

이 간행물의 다른 논문 (84건)